Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect

At present, no effective chemotherapy for pancreatic neuroendocrine carcinoma (PNEC) exists. However, anti-angiogenic therapy is expected to be effective for PNEC, a hypervascular tumor. We treated PNEC and hypovascular pancreatic ductal cell carcinoma (DCC) cell lines with the anti-vascular endothe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: KASUYA, KAZUHIKO, NAGAKAWA, YUICHI, SUZUKI, MINAKO, TANAKA, HIROAKI, OHTA, HIROSHI, ITOI, TAKAO, TSUCHIDA, AKIHIKO
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2011
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440813/
https://ncbi.nlm.nih.gov/pubmed/22977618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.349
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars